Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.54 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | JAK2 | O60674 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL187855 | 0.82 | CA2 (0.54) | GAALMNAMAPTJAK2CA2 | |
| SCHEMBL11320622 | 0.78 | TSHR (0.50) | GAALMNAMAPTJAK2CA2 | |
| SCHEMBL15501054 | 0.78 | CA2 (0.56) | GAALMNAMAPTJAK2CA2 | |
| SCHEMBL10035451 | 0.73 | L3MBTL1 (0.42) | GAALMNAHPGDALDH1A1KDM4E | |
| SCHEMBL14925378 | 0.73 | MEN1 (0.43) | LMNAMAPTTP53TSHRHPGD | |
| SCHEMBL17563713 | 0.73 | FABP7 (0.35) | GAALMNAMAPTJAK2CA2 | |
| SCHEMBL365525 | 0.73 | ALDH1A1 (0.50) | GAALMNAMAPTTSHRALDH1A1 | |
| SCHEMBL1638392 | 0.73 | CA1 (0.62) | LMNAMAPTCA2TP53CA1 | |
| SCHEMBL9132 | 0.73 | KDM4E (0.46) | LMNATSHRALDH1A1KDM4EALOX15 | |
| SCHEMBL14926315 | 0.73 | HTR7 (0.42) | GAALMNAMAPTHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 178 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118994216-A | 2-Boron ester-norbornene and use thereof and polymer containing alkenyl boron ester in main chain | 北京大学 | 2024-11-22 | — | — | CN | claimed |
| US-5741870-A | HAVING AT LEAST ONE BORONIC ACID ESTER GROUP BONDED TO AN SP3 CARBON ATOM OF THE POLYOLEFIN | KURARAY CO., LTD. (JP) | 1998-04-21 | — | — | US | claimed |
| US-20240239816-A1 | BORONO-PHENYLALANINE DERIVATIVE | STELLA PHARMA CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | LG CHEM, LTD (KR) | 2024-06-27 | — | — | US | disclosed |
| WO-2024100095-A1 | COMPOUNDS AND THEIR USE | KING’S COLLEGE LONDON (GB) | 2024-05-16 | — | — | WO | disclosed |
| EP-4361159-A1 | BORONO-PHENYLALANINE DERIVATIVE | Stella Pharma Corporation (JP) | 2024-05-01 | — | — | EP | disclosed |
| EP-4302830-A2 | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | Gilead Sciences, Inc. (US) | 2024-01-10 | — | — | EP | disclosed |
| US-11814393-B2 | Substituted guanidine compounds | UBE CORPORATION (JP) | 2023-11-14 | — | — | US | disclosed |
| WO-2023190878-A1 | TETRAHYDRONAPHTHALENE DERIVATIVE | Ａｔｒａｎｓｅｎ Ｐｈａｒｍａ株式会社 | 2023-10-05 | — | — | WO | disclosed |
| EP-3960735-B1 | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | GILEAD SCIENCES INC (US) | 2023-09-13 | — | — | EP | disclosed |
| US-20230150974-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-18 | — | — | US | disclosed |
| EP-1228850-A1 | Method for producing ethylene-vinyl alcohol copolymer resin composition | KURARAY CO., LTD. (JP) | 2002-08-07 | — | — | EP | disclosed |
| US-6398059-B1 | Fuel container | KURARAY CO., LTD. (JP) | 2002-06-04 | — | — | US | disclosed |
| EP-1166892-A2 | A method of producing a shaped article having excellent barrier properties | Kuraray Co., Ltd. (JP) | 2002-01-02 | — | — | EP | disclosed |
| EP-1108653-A1 | FUEL CONTAINER | KURARAY CO., LTD. (JP) | 2001-06-20 | — | — | EP | disclosed |
| EP-0616010-B1 | Resin composition | KURARAY CO (JP) | 1998-11-04 | — | — | EP | disclosed |
| US-5741870-A | HAVING AT LEAST ONE BORONIC ACID ESTER GROUP BONDED TO AN SP3 CARBON ATOM OF THE POLYOLEFIN | KURARAY CO., LTD. (JP) | 1998-04-21 | — | — | US | disclosed |
| US-5571871-A | Resin composition | KURARAY CO., LTD. (JP) | 1996-11-05 | — | — | US | disclosed |
| US-5466748-A | Resin composition | KURARAY CO., LTD. (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0616010-A2 | Resin composition | KURARAY CO., LTD. (JP) | 1994-09-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240208991-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CCNL2, UBE2L3 | GAA 3747/4885LMNA 1970/4885MAPT 3527/4885 |
| US-20230150974-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | GAA 9/4885LMNA 225/4885MAPT 2074/4885 |
| US-20240239816-A1 | BORONO-PHENYLALANINE DERIVATIVE | SLC7A1, SLC1A5, LATS2 | GAA 490/4885LMNA 2635/4885MAPT 874/4885 |
| US-11814393-B2 | Substituted guanidine compounds | GMPS, PDE3B, GUCY1A2 | GAA 56/4885LMNA 1713/4885MAPT 1549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.